Original Research
Published on 29 Sep 2023
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1166666
- 2,475 views
- 5 citations
Type at least 3 characters
2,713 articles
Original Research
Published on 28 Sep 2023
Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137966
- 2,812 views
Editorial
Published on 28 Sep 2023
Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1289756
- 1,919 views
Perspective
Published on 26 Sep 2023
Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1278402
- 1,553 views
- 1 citation
Review
Published on 26 Sep 2023
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1251100
- 12,255 views
- 17 citations
Review
Published on 26 Sep 2023
Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1256585
- 4,943 views
- 11 citations
Review
Published on 22 Sep 2023
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1184079
- 18,824 views
- 61 citations
Review
Published on 21 Sep 2023
Evolution by innovation as a driving force to improve TCR-T therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1216829
- 7,025 views
- 3 citations
Review
Published on 20 Sep 2023
Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1265347
- 6,661 views
- 18 citations
Correction
Published on 20 Sep 2023
Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1291026
- 951 views
Mini Review
Published on 19 Sep 2023
Post-translational modifications and their implications in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1240115
- 9,891 views
- 34 citations
Original Research
Published on 19 Sep 2023
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1269751
- 4,615 views
- 4 citations
Mini Review
Published on 18 Sep 2023
Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1248097
- 2,491 views
Original Research
Published on 13 Sep 2023
Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1228185
- 3,052 views
- 5 citations
Review
Published on 12 Sep 2023
The multifaceted roles of matrix metalloproteinases in lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1195426
- 4,226 views
- 22 citations
Original Research
Published on 11 Sep 2023
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1249649
- 3,318 views
- 6 citations